SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Lyell Immunopharma Inc. (LYEL) on Wednesday reported a loss of $38.8 million in its third quarter.
The South San Francisco, California-based company said it had a loss of $2.13 per share.
The biotechnology firm posted revenue of $15,000 in the period.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LYEL at https://www.zacks.com/ap/LYEL
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
